A study on deep feature extraction to detect and classify Acute Lymphoblastic Leukemia (ALL)
0
🤿
Sign in to get full access
Overview
- Acute lymphoblastic leukemia (ALL) is a type of blood cancer that primarily affects adults and children.
- This study investigates the use of deep learning, specifically Convolutional Neural Networks (CNNs), for the detection and classification of ALL.
- Conventional diagnostic techniques for ALL, such as bone marrow biopsy, can be costly and prone to human error.
- The research aims to improve diagnostic accuracy by utilizing automated technologies.
Plain English Explanation
The study explores the potential of deep learning, a type of artificial intelligence, to help detect and classify a form of blood cancer called acute lymphoblastic leukemia (ALL). Detecting and classifying ALL can be challenging with traditional methods, such as bone marrow biopsies, which can be expensive and may rely on human judgment, potentially leading to mistakes.
By using deep learning algorithms, the researchers hoped to develop a more accurate and automated way to diagnose ALL. They tested various pre-trained deep learning models, like InceptionV3 and ResNet101, to analyze images of blood smears and extract relevant features. They then used different feature selection techniques, such as ANOVA and Recursive Feature Elimination, to identify the most important characteristics.
Finally, the researchers applied various machine learning methods, including Naive Bayes, Random Forest, and Support Vector Machines, to classify the features and diagnose ALL. The ResNet101 model achieved the highest accuracy, at 87%, closely followed by DenseNet121 and VGG19.
The study suggests that deep learning-based models have the potential to reduce the need for medical specialists and improve the speed and accuracy of ALL diagnosis. To further enhance the models' performance, the researchers recommend expanding and diversifying the datasets, as well as exploring more advanced deep learning architectures, such as transformers.
Technical Explanation
The study investigates the use of Convolutional Neural Networks (CNNs), a type of deep learning model, for the detection and classification of acute lymphoblastic leukemia (ALL) from blood smear images. Conventional diagnostic techniques, such as bone marrow biopsy, can be costly and prone to human error, so the researchers aimed to develop an automated and more accurate approach.
The researchers utilized a variety of pre-trained CNN models, including InceptionV3, ResNet101, VGG19, DenseNet121, MobileNetV2, and DenseNet121, to extract features from the blood smear images. They then employed various feature selection techniques, such as ANOVA, Recursive Feature Elimination (RFE), Random Forest, Lasso, and Principal Component Analysis (PCA), to identify the most relevant features.
Following the feature extraction and selection process, the researchers applied machine learning algorithms, including Naive Bayes, Random Forest, Support Vector Machine (SVM), and K-Nearest Neighbours (KNN), to classify the features and detect the presence of ALL.
The results showed that the ResNet101 model achieved the highest accuracy, at 87%, closely followed by DenseNet121 and VGG19. The study suggests that CNN-based models have the potential to reduce the need for medical specialists and improve the speed and accuracy of ALL diagnosis.
Critical Analysis
The study provides a comprehensive investigation into the use of deep learning, specifically CNNs, for the detection and classification of acute lymphoblastic leukemia (ALL) from blood smear images. The researchers leveraged a variety of pre-trained CNN models and feature selection techniques to identify the most relevant features for accurate diagnosis.
One key limitation of the study is the dataset size and diversity. The researchers acknowledge that expanding and diversifying the dataset could further improve the models' performance. Additionally, the study suggests that exploring more advanced deep learning architectures, such as transformers, may be a promising avenue for future research.
While the results demonstrate the potential of CNN-based models for early diagnosis of ALL, it is important to consider the context and real-world application of such technologies. The researchers emphasize the need to reduce the reliance on medical specialists, but it is crucial to ensure that these automated systems are thoroughly validated and integrated into clinical practice in a way that enhances, rather than replaces, the expertise of healthcare professionals.
Conclusion
This study highlights the promising use of deep learning, specifically Convolutional Neural Networks (CNNs), for the detection and classification of acute lymphoblastic leukemia (ALL) from blood smear images. By leveraging pre-trained CNN models and various feature selection techniques, the researchers were able to achieve an impressive accuracy rate of 87% with the ResNet101 model.
The findings suggest that automated deep learning systems have the potential to improve the speed and accuracy of ALL diagnosis, potentially reducing the reliance on medical specialists. However, the researchers acknowledge the need to expand and diversify the dataset, as well as explore more advanced deep learning architectures, to further enhance the models' performance.
Overall, this study highlights the promising role of deep learning in the medical field, particularly in the context of early diagnosis of blood cancers. As the field continues to evolve, it will be crucial to carefully integrate these technologies into clinical practice while ensuring they complement, rather than replace, the expertise of healthcare professionals.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🤿
0
A study on deep feature extraction to detect and classify Acute Lymphoblastic Leukemia (ALL)
Sabit Ahamed Preanto (4IR Research Cell Daffodil International University, Dhaka, Bangladesh), Md. Taimur Ahad (4IR Research Cell Daffodil International University, Dhaka, Bangladesh), Yousuf Rayhan Emon (4IR Research Cell Daffodil International University, Dhaka, Bangladesh), Sumaya Mustofa (4IR Research Cell Daffodil International University, Dhaka, Bangladesh), Md Alamin (4IR Research Cell Daffodil International University, Dhaka, Bangladesh)
Acute lymphoblastic leukaemia (ALL) is a blood malignancy that mainly affects adults and children. This study looks into the use of deep learning, specifically Convolutional Neural Networks (CNNs), for the detection and classification of ALL. Conventional techniques for ALL diagnosis, such bone marrow biopsy, are costly and prone to mistakes made by hand. By utilising automated technologies, the research seeks to improve diagnostic accuracy. The research uses a variety of pre-trained CNN models, such as InceptionV3, ResNet101, VGG19, DenseNet121, MobileNetV2, and DenseNet121, to extract characteristics from pictures of blood smears. ANOVA, Recursive Feature Elimination (RFE), Random Forest, Lasso, and Principal Component Analysis (PCA) are a few of the selection approaches used to find the most relevant features after feature extraction. Following that, machine learning methods like Naive Bayes, Random Forest, Support Vector Machine (SVM), and K-Nearest Neighbours (KNN) are used to classify these features. With an 87% accuracy rate, the ResNet101 model produced the best results, closely followed by DenseNet121 and VGG19. According to the study, CNN-based models have the potential to decrease the need for medical specialists by increasing the speed and accuracy of ALL diagnosis. To improve model performance, the study also recommends expanding and diversifying datasets and investigating more sophisticated designs such as transformers. This study highlights how well automated deep learning systems do medical diagnosis.
Read more9/11/2024
📈
0
A Diagnostic Model for Acute Lymphoblastic Leukemia Using Metaheuristics and Deep Learning Methods
Amir Masoud Rahmani, Parisa Khoshvaght, Hamid Alinejad-Rokny, Samira Sadeghi, Parvaneh Asghari, Zohre Arabi, Mehdi Hosseinzadeh
Acute lymphoblastic leukemia (ALL) severity is determined by the presence and ratios of blast cells (abnormal white blood cells) in both bone marrow and peripheral blood. Manual diagnosis of this disease is a tedious and time-consuming operation, making it difficult for professionals to accurately examine blast cell characteristics. To address this difficulty, researchers use deep learning and machine learning. In this paper, a ResNet-based feature extractor is utilized to detect ALL, along with a variety of feature selectors and classifiers. To get the best results, a variety of transfer learning models, including the Resnet, VGG, EfficientNet, and DensNet families, are used as deep feature extractors. Following extraction, different feature selectors are used, including Genetic algorithm, PCA, ANOVA, Random Forest, Univariate, Mutual information, Lasso, XGB, Variance, and Binary ant colony. After feature qualification, a variety of classifiers are used, with MLP outperforming the others. The recommended technique is used to categorize ALL and HEM in the selected dataset which is C-NMC 2019. This technique got an impressive 90.71% accuracy and 95.76% sensitivity for the relevant classifications, and its metrics on this dataset outperformed others.
Read more8/13/2024
🤿
0
Deep Learning Algorithms for Early Diagnosis of Acute Lymphoblastic Leukemia
Dimitris Papaioannou, Ioannis Christou, Nikos Anagnou, Aristotelis Chatziioannou
Acute lymphoblastic leukemia (ALL) is a form of blood cancer that affects the white blood cells. ALL constitutes approximately 25% of pediatric cancers. Early diagnosis and treatment of ALL are crucial for improving patient outcomes. The task of identifying immature leukemic blasts from normal cells under the microscope can prove challenging, since the images of a healthy and cancerous cell appear similar morphologically. In this study, we propose a binary image classification model to assist in the diagnostic process of ALL. Our model takes as input microscopic images of blood samples and outputs a binary prediction of whether the sample is normal or cancerous. Our dataset consists of 10661 images out of 118 subjects. Deep learning techniques on convolutional neural network architectures were used to achieve accurate classification results. Our proposed method achieved 94.3% accuracy and could be used as an assisting tool for hematologists trying to predict the likelihood of a patient developing ALL.
Read more7/16/2024
🔎
0
A comprehensive study on Blood Cancer detection and classification using Convolutional Neural Network
Md Taimur Ahad, Sajib Bin Mamun, Sumaya Mustofa, Bo Song, Yan Li
Over the years in object detection several efficient Convolutional Neural Networks (CNN) networks, such as DenseNet201, InceptionV3, ResNet152v2, SEresNet152, VGG19, Xception gained significant attention due to their performance. Moreover, CNN paradigms have expanded to transfer learning and ensemble models from original CNN architectures. Research studies suggest that transfer learning and ensemble models are capable of increasing the accuracy of deep learning (DL) models. However, very few studies have conducted comprehensive experiments utilizing these techniques in detecting and localizing blood malignancies. Realizing the gap, this study conducted three experiments; in the first experiment -- six original CNNs were used, in the second experiment -- transfer learning and, in the third experiment a novel ensemble model DIX (DenseNet201, InceptionV3, and Xception) was developed to detect and classify blood cancer. The statistical result suggests that DIX outperformed the original and transfer learning performance, providing an accuracy of 99.12%. However, this study also provides a negative result in the case of transfer learning, as the transfer learning did not increase the accuracy of the original CNNs. Like many other cancers, blood cancer diseases require timely identification for effective treatment plans and increased survival possibilities. The high accuracy in detecting and categorization blood cancer detection using CNN suggests that the CNN model is promising in blood cancer disease detection. This research is significant in the fields of biomedical engineering, computer-aided disease diagnosis, and ML-based disease detection.
Read more9/11/2024